<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chamberlain AT</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Center for AIDS Research at Emory University</funding><funding>NIAID NIH HHS</funding><funding>Emory Covid-19 Response Collaborative</funding><funding>California Department of Health</funding><pagination>396-403</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8807152</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>225(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Reported coronavirus disease 2019 (COVID-19) cases underestimate true severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Data on all infections, including asymptomatic infections, are needed. To minimize biases in estimates from reported cases and seroprevalence surveys, we conducted a household-based probability survey and estimated cumulative incidence of SARS-CoV-2 infections adjusted for antibody waning.&lt;h4>Methods&lt;/h4>From August to December 2020, we mailed specimen collection kits (nasal swabs and blood spots) to a random sample of Georgia addresses. One household adult completed a survey and returned specimens for virus and antibody testing. We estimated cumulative incidence of SARS-CoV-2 infections adjusted for waning antibodies, reported fr</pubmed_abstract><journal>The Journal of infectious diseases</journal><pubmed_title>Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.</pubmed_title><pmcid>PMC8807152</pmcid><funding_grant_id>R01 AI143875</funding_grant_id><funding_grant_id>P30AI050409</funding_grant_id><funding_grant_id>3R01AI143875-02S1</funding_grant_id><pubmed_authors>Siegler AJ</pubmed_authors><pubmed_authors>Sullivan PS</pubmed_authors><pubmed_authors>Chamberlain AT</pubmed_authors><pubmed_authors>Shioda K</pubmed_authors><pubmed_authors>Hall EW</pubmed_authors><pubmed_authors>Fahimi M</pubmed_authors><pubmed_authors>Lopman BA</pubmed_authors><pubmed_authors>Sanchez T</pubmed_authors><pubmed_authors>Bradley H</pubmed_authors><pubmed_authors>Drenzek C</pubmed_authors><pubmed_authors>Luisi N</pubmed_authors><pubmed_authors>Toomey KE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.</name><description>&lt;h4>Background&lt;/h4>Reported coronavirus disease 2019 (COVID-19) cases underestimate true severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Data on all infections, including asymptomatic infections, are needed. To minimize biases in estimates from reported cases and seroprevalence surveys, we conducted a household-based probability survey and estimated cumulative incidence of SARS-CoV-2 infections adjusted for antibody waning.&lt;h4>Methods&lt;/h4>From August to December 2020, we mailed specimen collection kits (nasal swabs and blood spots) to a random sample of Georgia addresses. One household adult completed a survey and returned specimens for virus and antibody testing. We estimated cumulative incidence of SARS-CoV-2 infections adjusted for waning antibodies, reported fr</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-05-08T10:36:00.725Z</modification><creation>2025-02-19T01:47:04.046Z</creation></dates><accession>S-EPMC8807152</accession><cross_references><pubmed>34662409</pubmed><doi>10.1093/infdis/jiab522</doi></cross_references></HashMap>